The blog of the 2009 – 2017 Presidential Commission for the Study of Bioethical Issues

Monthly Archives: April, 2013

A Discussion on the Ethics of Incidental Findings

In a roundtable discussion, the Presidential Commission for the Study of Bioethical Issues (the Bioethics Commission) today discussed how incidental findings should be handled in the context of research, the clinic, and direct-to-consumer testing. What are the responsibilities of researchers to act on incidental findings? What is the duty of a clinician to her patient, […]

Share this article

Direct-to-Consumer Incidental Findings: the Intersection of Bioethics and Business Ethics

In today’s discussion of incidental findings, the Presidential Commission for the Study of Bioethical Issues (The Bioethics Commission) was eager to address the recent explosion of direct-to-consumer testing, and the role of the corporation in informing customers of incidental findings. In the case of incidental findings in direct-to-consumer testing, the ethical question becomes one of […]

Share this article

Incidental Findings in the Clinic: Extra Information and Extra Worry

During today’s meeting of The Presidential Commission for the Study of Bioethical Issues, it soon became clear that dealing with an incidental finding can involve more than just reporting to the patient impacted. As Haavi Morreim, J.D, Ph.D. Professor of Internal Medicine at The University of Tennessee Health Science Center, stated, there may be a […]

Share this article

When an Incidental Finding Saves a Life

During today’s meeting of the Presidential Commission for the Study of Bioethical Issues (the Bioethics Commission), a panel of experts discussed the ethical considerations associated with incidental findings that arise during research. Alex John London, M.A., Ph.D., Professor of Philosophy at Carnegie Mellon began by noting “The researcher may have a duty to act in […]

Share this article

An Overview of Incidental Findings

Today, the Presidential Commission for the Study of Bioethical Issues (the Bioethics Commission) addressed the role and impact of incidental findings in the clinic, in research, and in the new emerging businesses of direct-to-consumer testing. As Amy Gutmann, Ph.D., Chair of the Bioethics Commission, noted “Emerging medical technologies, changing cost structures, and evolving medical practice […]

Share this article

Live From Washington, D.C.

Welcome to the blog for the thirteenth public meeting of the Presidential Commission for the Study of Bioethical Issues (the Bioethics Commission). The Bioethics Commission is meeting in Washington, D.C. today, April 30th, from 9am to 5pm, EST. At this meeting the Bioethics Commission will begin work on its next project, the ethical implications of […]

Share this article

Bioethics Commission Develops Ethical Framework—Guidance for National-Level Review of Higher Risk Pediatric Research Protocols

The central tenet of pediatric research ethics is that it should not pose greater than minimal risk (or the risks of daily life) to participants, and, when greater risk cannot be avoided in research, there must be a commensurate potential for direct benefit to pediatric participants or benefit to an identifiable class of children. Only […]

Share this article

What is anthrax vaccine adsorbed and what do we know about it?

Anthrax is an infection of the skin, intestinal tract, or lungs caused by exposure to spores of the bacterium, Bacillus anthracis. Although several types of antibiotics are approved by the U.S. Food and Drug Administration (FDA) to prevent and treat anthrax, such antibiotics do not provide long-term protection against the persistence of dormant spores. Data […]

Share this article

Bioethics Commission Kicks Off Privacy and Progress Webinar Series

The Presidential Commission for the Study of Bioethical Issues (The Bioethics Commission), along with the Genetic Alliance, recently kicked off a new yearlong webinar series. The series is based on The Bioethics Commission’s report, Privacy and Progress in Whole Genome Sequencing. The report concludes that “to realize the enormous promise that whole genome sequencing holds […]

Share this article

In Safeguarding Children, Commission provides guidance for application of section 407

Most pediatric research can be approved by an institutional review board (IRB) if it poses only minimal risk, offers the prospect of direct benefit, or yields vitally important generalizable information about the participants’ condition. When a pediatric research proposal does not fit within these confines, to move forward, it must be elevated to national-level review […]

Share this article

About blog.Bioethics.gov

This is a space for the members and staff of the 2009 -2017 Presidential Commission for the Study of Bioethical Issues to communicate with the public about the work of the commission and to discuss important issues in bioethics.

As of January 15th, 2017 this blog will no longer be updated but continues to be available as an archive of the work of the 2009-2017 Presidential Commission for the Study of Bioethical Issues

Learn more about the 2009 - 2017 Presidential Commission for the Study of Bioethical Issues.